Travatan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Conditions:   Glaucoma;   Ocular HypertensionInterventions:   Drug: bimatoprost 0.01%;   Drug: travoprost 0.004%;   Drug: timolol 0.5%;   Drug: hypromellose 0.3%Sponsor:   AllerganActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2014 Category: Research Source Type: clinical trials

Global DuoTrav® Study
Conditions:   Open Angle Glaucoma;   Ocular HypertensionInterventions:   Drug: Beta-blocker monotherapy;   Drug: Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solutionSponsor:   Alcon ResearchCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2013 Category: Research Source Type: clinical trials

Global DuoTrav® Study
Conditions:   Open Angle Glaucoma;   Ocular HypertensionInterventions:   Drug: Beta-blocker monotherapy;   Drug: Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solutionSponsor:   Alcon ResearchActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2013 Category: Research Source Type: clinical trials

Global DuoTrav® Study
Conditions:   Open Angle Glaucoma;   Ocular HypertensionInterventions:   Drug: Beta-blocker monotherapy;   Drug: Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solutionSponsor:   Alcon ResearchCompleted - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2013 Category: Research Source Type: clinical trials